6533b837fe1ef96bd12a1d99

RESEARCH PRODUCT

Cervical spondylotic myelopathy: Changes of fractional anisotropy in the spinal cord and magnetic resonance spectroscopy of the primary motor cortex in relation to clinical symptoms and their duration

Christian BlumeMarc A. BrockmannHans ClusmannMartin WiesmannR.f. GohmannR.f. GohmannM. ZvyagintsevChristian-andreas MuellerVerena Mainz

subject

Malemedicine.medical_specialtyMagnetic Resonance SpectroscopyTime FactorsUrologyCreatineSpinal Cord Diseases030218 nuclear medicine & medical imaging03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSpondylotic myelopathyFractional anisotropyHumansMedicineRadiology Nuclear Medicine and imagingIn patientAgedAspartic Acidbusiness.industryMotor CortexPrecentral gyrusGeneral MedicineMiddle AgedCreatineSpinal cordmedicine.anatomical_structurechemistry030220 oncology & carcinogenesisCervical VertebraeAnisotropyFemaleSpondylosisPrimary motor cortexbusinessBiomarkersInositolNeck Disability Index

description

Abstract Objective To determine the changes in fractional anisotropy (FA) at the proximal spinal cord and in magnetic resonance spectroscopy (MRS) of the precentral gyrus in patients with cervical spondylotic myelopathy (CSM) with respect to clinical symptoms and their duration. Material and Methods 20 patients with CSM (7 female; mean age 64.6 ± 10.5 years) and 18 age/sex matched healthy controls (9 female; mean age 63.5 ± 6.6 years) were prospectively included. Clinical data (modified Japanese Orthopaedic Association Score (mJOA) and Neck Disability Index (NDI)) and 3T MR measurements including DTI at the spinal cord (level C2/3) with FA and MRS of the left and right precentral gyrus were taken. Clinical correlations and regression analyses were performed. Results Mean clinical scores of patients were significantly different to controls (mJOA; CSM: 10.2 ± 2.9; controls: 18.0 ± 0.0, p  ); FA was significantly lower in patients (CSM: 0.645 ± 0.067; controls: 0.699 ± 0.037, p = 0.005). MRS showed significantly lower metabolite concentrations between both groups: creatine (Cr) (CSM: 46.46±7.64; controls: 51.36±5.76, p = 0.03) and N-acetylaspartate (NAA) (CSM: 93.94±19.22; controls: 107.24±20.20, p = 0.05). Duration of symptoms ≤6 months was associated with increased myo-inositol (Ins) (61.58±17.76; 44.44±10.79; p = 0.02) and Ins/Cr ratio (1.36±0.47; 0.96±0.18; p = 0.014) compared to symptoms >6 months. Conclusion Metabolic profiles of the precentral gyrus and FA in the uppermost spinal cord differ significantly between patients and healthy controls. Ins, thought to be a marker of endogenous neuroinflammatory response, is high in the early course of CSM and normalizes over time.

https://doi.org/10.1016/j.ejrad.2019.04.009